Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

504 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Global challenges in access to diagnostics and treatment for neuroendocrine tumor (NET) patients.
Dureja S, McDonnell M, Van Genechten D, Bouvier C, Kolarova T, O'Toole D, Singh H, Chen J, Howe J, Singh S, Rodien-Louw C, Leyden S, Gellerman E, Herman J, Pavel M; International Neuroendocrine Cancer Alliance (INCA). Dureja S, et al. J Neuroendocrinol. 2023 Jun;35(6):e13310. doi: 10.1111/jne.13310. Epub 2023 Jun 23. J Neuroendocrinol. 2023. PMID: 37351944 Review.
Expanding Role of Gastroenterology in the Staging of Digestive Neuroendocrine Tumors: Updates From the American Joint Committee on Cancer Version 9 Cancer Staging System.
Ge PS, Shi C, Asare E, Washington MK, O'Toole D; American Joint Committee on Cancer Expert Panel on Neuroendocrine Tumors. Ge PS, et al. Clin Gastroenterol Hepatol. 2024 Mar;22(3):448-451. doi: 10.1016/j.cgh.2023.10.033. Epub 2023 Dec 5. Clin Gastroenterol Hepatol. 2024. PMID: 38056801 No abstract available.
Screening and surveillance practices for Multiple Endocrine Neoplasia type 1-related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence (ENETS CoE)-An ENETS MEN1 task force questionnaire study.
Pieterman CRC, Grozinsky-Glasberg S, O'Toole D, Howe JR, Ambrosini V, Belli SH, Andreassen M, Begum N, Denecke T, Faggiano A, Falconi M, Grey J, Knigge UP, Kolarova T, Niederle B, Nieveen van Dijkum E, Partelli S, Pascher A, Rindi G, Ruszniewski P, Stättner S, Vandamme T, Valle JW, Vullierme MP, Welin S, Perren A, Bartsch DK, Kaltsas GK, Valk GD. Pieterman CRC, et al. Among authors: o toole d. J Neuroendocrinol. 2024 Nov 26:e13468. doi: 10.1111/jne.13468. Online ahead of print. J Neuroendocrinol. 2024. PMID: 39587981
PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly.
O'Toole D, Kunz PL, Webb SM, Goldstein G, Khawaja S, McDonnell M, Boiziau S, Gueguen D, Houchard A, Ribeiro-Oliveira A Jr, Prebtani A. O'Toole D, et al. Adv Ther. 2023 Feb;40(2):671-690. doi: 10.1007/s12325-022-02360-6. Epub 2022 Dec 11. Adv Ther. 2023. PMID: 36502449 Free PMC article.
Correction to: PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly.
O'Toole D, Kunz PL, Webb SM, Goldstein G, Khawaja S, McDonnell M, Boiziau S, Gueguen D, Houchard A, Ribeiro-Oliveira A Jr, Prebtani A. O'Toole D, et al. Adv Ther. 2024 Jun;41(6):2531-2533. doi: 10.1007/s12325-024-02829-6. Adv Ther. 2024. PMID: 38480663 No abstract available.
504 results